PDCL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.492000E-01
Normal-vs-Stage2
4.412200E-01
Normal-vs-Stage3
4.548400E-01
Normal-vs-Stage4
8.161200E-01
Stage1-vs-Stage2
3.658200E-01
Stage1-vs-Stage3
9.559600E-01
Stage1-vs-Stage4
1.494630E-01
Stage2-vs-Stage3
5.170000E-01
Stage2-vs-Stage4
2.277800E-01
Stage3-vs-Stage4
3.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.440000E-01
Normal-vs-AfricanAmerican
8.153600E-01
Normal-vs-Asian
4.800600E-01
Caucasian-vs-AfricanAmerican
4.039800E-01
Caucasian-vs-Asian
8.455600E-01
AfricanAmerican-vs-Asian
4.173800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.922400E-01
Normal-vs-Female
4.043200E-01
Male-vs-Female
7.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.431600E-01
Normal-vs-Age(41-60Yrs)
5.807200E-01
Normal-vs-Age(61-80Yrs)
3.991600E-01
Normal-vs-Age(81-100Yrs)
6.769800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.970200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.618200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.417900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.680820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.951800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.309200E-01
Normal-vs-Daily Drinker
2.923400E-01
Normal-vs-Weekly Drinker
6.990400E-01
Normal-vs-Occasional Drinker
8.564400E-01
Normal-vs-Social Drinker
2.113200E-01
Non Drinker-vs-Daily Drinker
9.830800E-01
Non Drinker-vs-Weekly Drinker
2.963600E-01
Non Drinker-vs-Occasional Drinker
9.715700E-02
Non Drinker-vs-Social Drinker
9.146600E-01
Daily Drinker-vs-Weekly Drinker
2.879200E-01
Daily Drinker-vs-Occasional Drinker
9.367800E-02
Daily Drinker-vs-Social Drinker
8.948600E-01
Weekly Drinker-vs-Occasional Drinker
6.728400E-01
Weekly Drinker-vs-Social Drinker
3.297600E-01
Occasional Drinker-vs-Social Drinker
1.129830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.957000E-01
Normal-vs-Grade 2
8.382000E-01
Normal-vs-Grade 3
8.796200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.578600E-01
Grade 1-vs-Grade 3
8.063000E-01
Grade 1-vs-Grade 4
8.957000E-01
Grade 2-vs-Grade 3
3.246200E-01
Grade 2-vs-Grade 4
8.382000E-01
Grade 3-vs-Grade 4
8.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.343400E-01
Normal-vs-NonDiabetic
4.169200E-01
Diabetic-vs-NonDiabetic
8.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.514400E-01
Normal-vs-NoPancreatitis
4.880600E-01
Pancreatitis-vs-NoPancreatitis
4.749400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.020600E-01
Normal-vs-N1
4.795400E-01
N0-vs-N1
9.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.533800E-01
Normal-vs-TP53-NonMutant
2.512200E-01
TP53-Mutant-vs-TP53-NonMutant
6.373600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
